Profiles: Page 6

The latest opinion pieces by industry thought leaders

  • A portrait of Dr. Pam Diamond framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Dr. Pam Diamond
    Image attribution tooltip

    DE&I Champions: Dr. Pam Diamond

    The chief medical officer and co-founder of Curavit Clinical Research is bringing a new level of inclusiveness to clinical trials.

    Meagan Parrish • Sept. 6, 2022
  • A portrait of Dr. Michael Hayden framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Dr. Michael Hayden
    Image attribution tooltip

    Legacy Leaders: Dr. Michael Hayden

    The CEO at Prilenia has an unwavering dedication to address the needs of HD patients and their families.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Dr. Jula Inrig framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Dr. Jula Inrig
    Image attribution tooltip

    Innovators: Dr. Jula Inrig

    The longtime devotee to kidney disease research is using a novel trial design to advance treatments for rare conditions at Travere.

    Meagan Parrish • Sept. 6, 2022
  • A portrait of Dr. Judith Klimovsky framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Dr. Judith Klimovsky
    Image attribution tooltip

    Innovators: Dr. Judith Klimovsky

    The executive vice president and chief business officer of Genmab is using decades of experience in oncology R&D to fuel advances in antibody-drug conjugates. 

    Meagan Parrish • Sept. 6, 2022
  • A portrait of Dominique Demolle framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Dominique Demolle
    Image attribution tooltip

    Tech Wizards: Dominique Demolle

    How the CEO of Cognivia is revolutionizing drug development with psychonomics.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Dawn Berry framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Dawn Berry
    Image attribution tooltip

    Entrepreneurs: Dawn Barry

    The co-founder and president of LunaPBC is seeking to eliminate the middlemen in drug development by connecting patients — and their real-world data — directly with researchers.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of David Katz framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by David Katz
    Image attribution tooltip

    Entrepreneurs: David Katz

    As the founder and chief scientific officer of Sparrow Pharmaceuticals, David Katz is breathing new life into drugs that have previously been shelved.

    Michael Gibney • Sept. 6, 2022
  • A portrait of Dr. Cristian Massacesi framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Dr. Cristian Massacesi
    Image attribution tooltip

    Innovators: Dr. Cristian Massacesi

    With the goal of redefining how medicines are made, the CMO and oncology CDO is transforming AstraZeneca’s oncology development.

    Meagan Parrish • Sept. 6, 2022
  • A portrait of Chris Round framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Chris Round
    Image attribution tooltip

    Legacy Leaders: Chris Round

    The president of EMD Serono, the U.S. and Canadian healthcare business unit of Merck KGaA, Darmstadt, Germany, has the company firing on all cylinders for near- and long-term growth.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Charlene Stern framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Charlene Stern
    Image attribution tooltip

    Disrupters: Charlene Stern

    How the chief lawyer of Editas Medicine is using a multi-lens approach to bolster the development of game-changing genomic medicines.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Carol Lynch framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Carol Lynch
    Image attribution tooltip

    Legacy Leaders: Carol Lynch

    The chief business officer for Sandoz combines a shrewd business sense with a generous approach to leadership.

    Alexandra Pecci • Sept. 6, 2022
  • A portrait of Carl Turner framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Carl Turner
    Image attribution tooltip

    Disrupters: Carl Turner

    How Klick’s first-ever chief brand strategy officer is relying on collaboration to advance innovative strategies for clients and opportunities for people of color.

    Meagan Parrish • Sept. 6, 2022
  • A portrait of Bobak Azamian framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Bobak Azamian
    Image attribution tooltip

    Entrepreneurs: Dr. Bobak Azamian

    The CEO is bringing his vision for innovative eye therapies to Tarsus Pharmaceuticals.

    Meagan Parrish • Sept. 6, 2022
  • A portrait of Beth Crouse framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Beth Crouse
    Image attribution tooltip

    Entrepreneurs: Beth Crouse

    The 2nd Spark CEO is on a mission to create ‘brand fans’ and bring meaningful marketing experiences to healthcare.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Ben Yerxa framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Ben Yerxa
    Image attribution tooltip

    Entrepreneurs: Ben Yerxa

    The CEO in retinal diseases sees opportunities for drug development success by merging the work of a gene therapy startup with venture philanthropy.

    Meagan Parrish • Sept. 6, 2022
  • A portrait of Dr. Barbara Wirostko framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Dr. Barbara Wirostko
    Image attribution tooltip

    Entrepreneurs: Dr. Barbara Wirostko

    Qlaris Bio’s CMO and co-founder has her sights on bringing life-changing treatments to patients with debilitating eye diseases.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Barbara Klencke framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Barbara Klencke
    Image attribution tooltip

    Innovators: Dr. Barbara Klencke

    The chief medical officer at Sierra Oncology, a GSK company, is working to make high-impact changes for rare cancer patients.

    Meagan Parrish • Sept. 6, 2022
  • A portrait of Baba Shetty framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Baba Shetty
    Image attribution tooltip

    Tech Wizards: Baba Shetty

    The pragmatic president of technology and data solutions at Syneos Health helps healthcare companies do what they imagine.

    Meagan Parrish • Sept. 6, 2022
  • A portrait of Armon Sharei framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Armon Sharei
    Image attribution tooltip

    Entrepreneurs: Armon Sharei

    The CEO of SQZ Biotech is leveraging a technology platform that is simple in its design yet targeted at making cell therapy to break down barriers to the treatments.

    Michael Gibney • Sept. 6, 2022
  • A portrait of Ann Barnes framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Ann Barnes
    Image attribution tooltip

    DE&I Champions: Ann Barnes

    The CEO of Intelligent Medical Objects is growing her company’s diversity initiatives — and its bottom line.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Andrew Miller framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Andrew Miller
    Image attribution tooltip

    Entrepreneurs: Andrew Miller

    The founder and COO of Karuna Therapeutics is leveraging a combination of persistence and adaptability to scale up the biopharmaceutical company.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Dr. Amy C. Peterson framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Dr. Amy C. Peterson
    Image attribution tooltip

    Innovators: Dr. Amy Peterson

    The president and chief operating officer of CytomX is fighting to change the course of cancer as a leader in cutting-edge treatments.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Amanda Ryan framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Amanda Ryan
    Image attribution tooltip

    DE&I Champions: Amanda Ryan

    G3 Life Sciences’ president is lighting a fire to increase access to healthcare and diversity in trials.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Adrelia Allen framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Adrelia Allen
    Image attribution tooltip

    DE&I Champions: Adrelia Allen

    Merck & Co.’s senior director of clinical trial patient diversity is transforming the pharma giant’s approach to inclusion and equality.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Abigail Jenkins framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Abigail Jenkins
    Image attribution tooltip

    Disrupters: Abigail Jenkins

    With the belief that empathy is critical to leadership, the former chief commercial and business officer of Lyndra Therapeutics has a strong track record of building teams and accelerating progress.

    Meagan Parrish • Sept. 6, 2022